| Aug 28 |
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
|
| Aug 9 |
23andMe shuts down therapeutics discovery unit, launching GLP-1 telehealth offering
|
| Aug 9 |
23andMe Holding Co. (ME) Q1 2025 Earnings Call Transcript
|
| Aug 8 |
23andMe GAAP EPS of -$0.14, revenue of $40.42M misses by $11.63M
|
| Aug 8 |
23andMe Reports First Quarter Fiscal 2025 Financial Results
|
| Aug 7 |
23andMe Q1 2025 Earnings Preview
|
| Aug 2 |
23andMe board rejects CEO Wojcicki’s take-private proposal
|
| Aug 2 |
23andMe says CEO’s take-private bid is insufficient
|
| Aug 2 |
Genetic testing firm 23andMe rejects CEO's take-private offer
|
| Aug 2 |
23andMe Special Committee responds to CEO’s take-private proposal
|
